Medical Oncology
Medical Oncology is the branch of medicine concerned with the diagnosis, treatment and management of cancer using systemic therapies — treatments that work throughout the entire body rather than targeting a specific location. It is one of the most rapidly advancing and clinically significant specialties in modern medicine — combining deep scientific knowledge of Cancer Biology, molecular biology, immunology and pharmacology with compassionate, patient-centred clinical care. Medical oncologists are specialist physicians who design, oversee and coordinate the non-surgical treatment of cancer — working in close collaboration with surgical oncologists, radiation oncologists, pathologists, radiologists and other specialists to provide comprehensive, multidisciplinary cancer care.
Overview
Cancer is one of the leading causes of death worldwide — and its treatment requires a sophisticated, multidisciplinary approach. Medical oncology sits at the heart of this approach — providing the systemic treatments that reach cancer cells throughout the body, regardless of their location.
The field of medical oncology has been transformed over the past two decades by extraordinary scientific advances — particularly in the areas of targeted therapy, immunotherapy and precision medicine — enabling oncologists to treat many cancers with greater effectiveness and fewer side effects than ever before. The development of new systemic therapies continues to be one of the most active and exciting areas in all of medicine — driven by a deeper understanding of the molecular biology of cancer and the complex interactions between tumours and the immune system.
What Medical Oncologists Do
Medical oncologists are responsible for:
- Diagnosis and Staging — Interpreting diagnostic tests, biopsies, imaging and molecular profiling to confirm the diagnosis and determine the stage and characteristics of the cancer
- Treatment Planning — Designing individualised treatment plans — selecting the most appropriate systemic therapies based on the cancer type, stage, molecular profile and the patient's overall health and preferences
- Administering Systemic Therapy — Overseeing the administration of chemotherapy, immunotherapy, targeted therapy, hormone therapy and other systemic treatments
- Monitoring and Response Assessment — Regularly assessing the patient's response to treatment — adjusting the treatment plan as needed based on response, side effects and new information
- Managing Side Effects — Identifying and managing the side effects of cancer treatment — including nausea, fatigue, infection, anaemia and neuropathy
- Palliative Care — Providing symptom management and quality of life support for patients with advanced or incurable cancer
- Clinical Trials — Conducting and enrolling patients in clinical trials of new cancer therapies
- Multidisciplinary Team Leadership — Working with surgical oncologists, radiation oncologists, pathologists, radiologists, nurses and other specialists to provide coordinated, comprehensive cancer care
Systemic Therapies in Medical Oncology
Medical oncology encompasses a wide and growing range of systemic cancer therapies:
Chemotherapy
Chemotherapy uses cytotoxic drugs — drugs that kill rapidly dividing cells — to treat cancer. It was the first major systemic cancer treatment and remains an important part of cancer care for many cancer types. Chemotherapy drugs work by interfering with DNA replication, cell division or other essential cellular processes — killing cancer cells but also affecting some normal rapidly dividing cells (such as those in the bone marrow, gut lining and hair follicles), which is the basis for many of chemotherapy's well-known side effects.
Chemotherapy may be given:
- Before surgery (Neoadjuvant) — To shrink the tumour before surgical removal
- After surgery (Adjuvant) — To kill remaining cancer cells and reduce the risk of recurrence
- As the primary treatment — For cancers that cannot be surgically removed
- Palliatively — To control symptoms and slow disease progression in advanced cancer
Targeted Therapy
Targeted therapy uses drugs designed to attack specific molecular targets in cancer cells — such as mutated proteins, overexpressed receptors or specific signalling pathways — with greater precision than conventional chemotherapy. Targeted therapies exploit the specific molecular vulnerabilities of individual cancers — causing less damage to normal cells and often producing fewer side effects.
Examples of targeted therapies include:
- Tyrosine Kinase Inhibitors (TKIs) — Such as imatinib (for CML) and erlotinib (for lung cancer)
- Monoclonal Antibodies — Such as trastuzumab (Herceptin) for HER2-positive breast cancer and bevacizumab for anti-angiogenic therapy
- PARP Inhibitors — For BRCA-mutated breast and ovarian cancers
- CDK4/6 Inhibitors — For hormone receptor-positive breast cancer
Immunotherapy
Immunotherapy represents one of the most revolutionary advances in cancer treatment in recent decades — harnessing the body's own immune system to recognise and destroy cancer cells. The development of immune checkpoint inhibitors — drugs that release the brakes on the immune system, allowing it to attack cancer cells — has transformed the treatment of multiple cancers including melanoma, lung cancer, kidney cancer and others.
Types of immunotherapy include:
- Immune Checkpoint Inhibitors — Including anti-PD-1, anti-PD-L1 and anti-CTLA-4 antibodies
- CAR-T Cell Therapy — Engineering the patient's own T cells to recognise and attack cancer cells
- Cancer Vaccines — Stimulating the immune system to recognise and destroy cancer cells
- Cytokines — Including interferons and interleukins that stimulate immune activity
Hormone Therapy
Hormone therapy blocks or reduces the levels of hormones — particularly oestrogen and testosterone — that fuel certain hormone-sensitive cancers. It is a cornerstone of treatment for:
- Breast Cancer — Tamoxifen, aromatase inhibitors and fulvestrant for oestrogen receptor-positive breast cancer
- Prostate Cancer — Androgen deprivation therapy (ADT) for androgen-sensitive prostate cancer
Precision Medicine and Molecular Oncology
Precision medicine — also known as personalised medicine — is the approach of tailoring cancer treatment to the specific molecular characteristics of an individual patient's tumour. Advances in genomic sequencing and molecular profiling have enabled oncologists to identify the specific mutations, gene fusions and molecular alterations driving a patient's cancer — and to select targeted therapies that address those specific alterations.
Multi-omics approaches — including genomics, proteomics and metabolomics — are increasingly being used to characterise tumours comprehensively and identify new therapeutic targets — a research approach actively pursued by researchers including Dr. Nishant Kumar Rana at the University of Colorado Anschutz Medical Campus.
Research in Medical Oncology
Medical oncology is one of the most active areas of biomedical research — with new discoveries and new therapies emerging at an extraordinary pace:
Clinical Trials
Clinical trials are the engine of progress in medical oncology — testing new drugs, combinations and treatment strategies in patients to determine their safety and effectiveness. Oncologists and researchers at institutions including the University of Colorado Anschutz Medical Campus are at the forefront of clinical research — conducting trials that are shaping the future of cancer treatment.
Translational Research
Translational research — the process of translating discoveries in the laboratory into clinical treatments — is a cornerstone of modern medical oncology. Researchers working at the intersection of Cancer Biology and clinical medicine — studying how cancer cells survive, adapt and respond to treatment — are generating the insights that drive the next generation of cancer therapies.
Key Research Areas
Current areas of intense research in medical oncology include:
- Postpartum Breast Cancer — Understanding the unique biology of breast cancer arising in the postpartum period — including the role of molecules such as SEMA7A in tumour adaptation
- Tumour Microenvironment — Understanding how cancer cells interact with surrounding immune cells, blood vessels and stromal cells
- Cancer Immunology — Understanding how tumours evade immune detection and how to overcome this evasion
- Liquid Biopsy — Using blood-based tests to detect and monitor cancer through circulating tumour DNA and cells
- Resistance Mechanisms — Understanding how cancers develop resistance to targeted therapies and immunotherapy
Medical Oncology in India
India has a growing and increasingly sophisticated medical oncology infrastructure — with major cancer centres providing world-class cancer care:
- Tata Memorial Centre, Mumbai — India's premier cancer centre — one of the largest in Asia
- All India Institute of Medical Sciences (AIIMS), New Delhi — A leading centre for cancer diagnosis, treatment and research
- Regional Cancer Centres — A network of government-funded cancer centres across India
- Banaras Hindu University — Institute of Medical Sciences (IMS BHU) — An important centre for cancer research and treatment in North India
Indian oncologists and researchers — supported by ICMR and UGC fellowships — are making important contributions to global cancer research — both within India and at leading international institutions.
Subspecialties of Medical Oncology
Medical oncology encompasses several important subspecialties:
- Breast Oncology — Specialising in breast cancer treatment
- Thoracic Oncology — Lung and chest cancers
- Gastrointestinal Oncology — Cancers of the digestive system
- Genitourinary Oncology — Kidney, bladder and prostate cancers
- Haematologic Oncology — Leukaemia, lymphoma and myeloma
- Neuro-Oncology — Brain and nervous system cancers
- Gynaecologic Oncology — Cancers of the female reproductive system
- Paediatric Oncology — Cancer in children
Vision for Medical Oncology
The vision of medical oncology is a future in which every cancer patient receives treatment precisely tailored to the molecular characteristics of their tumour — with maximum effectiveness and minimum side effects. Advances in precision medicine, immunotherapy, liquid biopsy and artificial intelligence are bringing this vision closer to reality — and researchers across the world, including Indian scientists at institutions like the University of Colorado Anschutz Medical Campus, are at the forefront of this extraordinary scientific and medical journey.